Support Dr. Huffman's Research's Fundraising Page

Conquer cancer  with  your Giving Page
Conquer cancer with your Giving Page

WHY WE'RE FUNDRAISING WITH THE JIMMY FUND WALK TO FIGHT CANCER

 

Brandon Huffman, MD, is a medical oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, where he treats patients with gastrointestinal (GI) cancers and leads clinical research developing better therapies.

 

Dr. Huffman embodies Dana-Farber’s mission as he develops clinical trials translating innovative laboratory ideas into novel treatment regimens improving outcomes for patients. In this work, he partners with laboratory scientists and is the lead investigator on several early-phase trials. He is currently focused on the development of novel immunotherapy combinations and targeted therapies in GI cancers.

 

Your support is instrumental to Dr. Huffman’s research in developing new treatments. Specifically, philanthropy supports areas that are difficult to fund through federal grants, such as collecting biopsies from patients, genetically sequencing biopsies, conducting molecular analyses, and hiring clinical trial personnel for the ongoing study activities. Thank you for your consideration and support.  

 

Dr. Huffman is originally from Missouri. He received his Doctor of Medicine from the University of Missouri School of Medicine and completed his internal medicine residency at the Mayo Clinic in Rochester, Minnesota. He completed his fellowship in medical oncology at the Dana-Farber/Mass General Brigham Fellowship Program through where he was mentored by one of Dana-Farber’s expert clinician-investigators Dr. James Cleary and partnered with several Dana-Farber laboratory investigators like Drs. Alan D’Andrea, Andy Aguirre, Nilay Sethi, and Stephanie Dougan. Dr. Huffman has continued his collaboration with these laboratory- and physician-scientists since joining Dana-Farber Faculty. 

 

 

PROGRESS TO GOAL

Raised:$10,000
Goal:$0
1team member

THANK YOU TO OUR TEAM MEMBERS

C = Team Captain
NAME
AMOUNT RAISED
x0x
x$10,000.00x

THANK YOU TO OUR TEAM DONORS

NAME
AMOUNT
Event Honor Roll
John & Barbara Pekenia for Dr. Huffman
$10,000
I'm Living Proof buttons
Every dollar raised helps fuel Dana-Farber Cancer Institute's mission.
Together, we can defy cancer!














My Giving Page

Conquer cancer  with  your Giving Page
Conquer cancer with your Giving Page

Support Dr. Huffman's Research

 

Brandon Huffman, MD, is a medical oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, where he treats patients with gastrointestinal (GI) cancers and leads clinical research developing better therapies.

 

Dr. Huffman embodies Dana-Farber’s mission as he develops clinical trials translating innovative laboratory ideas into novel treatment regimens improving outcomes for patients. In this work, he partners with laboratory scientists and is the lead investigator on several early-phase trials. He is currently focused on the development of novel immunotherapy combinations and targeted therapies in GI cancers.

 

Your support is instrumental to Dr. Huffman’s research in developing new treatments. Specifically, philanthropy supports areas that are difficult to fund through federal grants, such as collecting biopsies from patients, genetically sequencing biopsies, conducting molecular analyses, and hiring clinical trial personnel for the ongoing study activities. Thank you for your consideration and support.  

 

Dr. Huffman is originally from Missouri. He received his Doctor of Medicine from the University of Missouri School of Medicine and completed his internal medicine residency at the Mayo Clinic in Rochester, Minnesota. He completed his fellowship in medical oncology at the Dana-Farber/Mass General Brigham Fellowship Program through where he was mentored by one of Dana-Farber’s expert clinician-investigators Dr. James Cleary and partnered with several Dana-Farber laboratory investigators like Drs. Alan D’Andrea, Andy Aguirre, Nilay Sethi, and Stephanie Dougan. Dr. Huffman has continued his collaboration with these laboratory- and physician-scientists since joining Dana-Farber Faculty. 

 

 

View More
View More